Login
Password
Remember Me
New large-scale DNA manufacturing facility in the UK Touchlight, a UK-based manufacturer of synthetic DNA, has received the first phase of...
Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology Collaboration combines Intellia’s proprietary genome editing...
Boehringer Ingelheim to expand veterinary vaccine capacity for emerging and transboundary diseases in France Boehringer Ingelheim announced an additional €100 million...
More articles from NEWS
True cost of sickle cell disease: $1.5 billion in lost productivity per year Sickle cell disease causes $1.5 billion in lost...
Record financing for the regenerative medicine sector through Q3 2020 The regenerative medicine sector attracted $15.9 billion in financing through just...
How to increase the number of European-based ATMP clinical trials? The latest report published by the Alliance for Regenerative Medicine (ARM),...
More articles from ANALYSES
A Z-RNA nanoswitch encoded by “junk DNA” turns-off immune responses against self In a paper published in the May 13th, 2021...
Novel nanotech improves cystic fibrosis antibiotic by 100,000-fold Cystic fibrosis is causing severe impairments to a person’s lungs, airways and digestive...
New research on why mutations in a gene leads to mitochondrial disease Image of mitochondria (yellow-green) around the cell nucleus (blue)....
More articles from SCIENTIFIC NEWS
